Esta web utiliza cookies para que podamos ofrecerte la mejor experiencia de usuario posible. La información de las cookies se almacena en tu navegador y realiza funciones tales como reconocerte cuando vuelves a nuestra web o ayudar a nuestro equipo a comprender qué secciones de la web encuentras más interesantes y útiles.
Martín J, Quiroga JA, Navas S, Pardo M,Carreño V. Cytokine 1999; 11: 267-273.
Transplantation of allogeneic CD34-selected peripheral stem cells does not prevent transmission of hepatitis C virus from an infected donor.
Tomás JF, Rodríguez-Iñigo E, Bartolomé J, Alegre A, Fernández-Rañada JM,Carreño V. Bone Marrow Transplant 1999; 24: 109-112.
Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B.
Ruiz-Moreno M, Otero M, Millán A, Castillo I, Cabrerizo M, Jiménez FJ, Oliva H, Ramón y Cajal S,Carreño V. Hepatology 1999; 29: 572-575.
Phylogenetic analysis of hepatitis GB virus type C/hepatitis G virus in Spanish patients with chronic hepatitis B or C virus infection.
López-Alcorocho JM, Amaro MJ, Cabrerizo M, Fogeda M, Castillo I, Bartolomé J,Carreño V. Intervirology 1998; 41: 233-237.
Analysis of the hepatitis B virus precore and ORF-X sequences in patients with antibody to hepatitis B e antigen with and whithout normal ALT levels
Cabrerizo M, Bartolomé J, Rodríguez-Iñigo E, López-Alcorocho JM, Cotonat T,Carreño V. J Med Virol 1998; 56: 294-299.
Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver and serum from chronic hepatitis C patients
Navas S, Martín J, Quiroga JA, Castillo I,Carreño V. J Virol 1998;72:1640-1646
Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff
Cabrerizo M, Bartolomé J, de Sequera P, Caramelo C,Carreño V. J Am Soc Nephrol 1997; 8: 1443-1147.
Hepatitis C and G virus infection and liver dysfunction after allogeneic bone marrow transplantation: Results from a prospective study
Rodríguez-Iñigo E, Tomás JF, Gómez-García de Soria V, Bartolomé J, Pinilla I, Amaro MJ,Carreño V, Fernández-Rañada JM. Blood 1997; 90: 1326-1331.
Activation of liver disease in healthy hepatitis B surface antigen carriers during interferon-alpha treatment.
Rodríguez-Iñigo E, Bartolomé J, López-Alcorocho JM, Cotonat T, Oliva H,Carreño V. J Med Virol 1997; 53: 76-80
Distribution of the predominant hepatitis B virus precore variants in hepatitis B e antigen-positive children and their effect on treatment response.
Cabrerizo M, Bartolomé J, Ruíz-Moreno M, Otero M, López-Alcorocho JM,Carreño V. Pediatric Res1996; 39: 980-984.
Patterns of immune responses to the host-encoded GOR and hepatitis C virus core-derived epitopes with relation to hepatitis C viremia, genotypes and liver disease severity
Quiroga JA, Pardo M, Navas S, Martín J,Carreño V. J Infect Dis 1996; 173: 300-305.
Hepatitis C virus genotypes in serum and liver of children with chronic hepatitis C.
Castillo I, Bartolomé J, Ruiz-Moreno M, Sánchez V, Navas S,Carreño V. Pediatric Res 1995; 38: 618-620.